Primmune Therapeutics is a clinical-stage therapeutics company dedicated to the design and development of systemically acting, orally administered, novel small molecule, toll-like receptor 7 (TLR7) agonists as immunotherapies for the treatment of cancer and viral diseases
Primmune Therapeutics is a clinical-stage therapeutics company dedicated to the design and development of systemically acting, orally administered, novel small molecule, toll-like receptor 7 (TLR7) agonists as immunotherapies for the treatment of cancer and viral diseases.